Author Archives: Colby Howard

Theodore Hanson’s M&A strengths at ASGN (ASGN) may support federal growth, but questions remain around his fit to drive AI and stabilize staffing cycles. Continue reading →

Christopher Bernard’s M&A expertise and clinical pipeline focus may align well with Metsera, Inc. (MTSR), supporting deal closure and integration goals. Continue reading →

Yang Wu’s track record at Microvast Holdings (MVST) raises questions about his fit to navigate liquidity challenges and deliver on urgent operational goals. Continue reading →

Todd Gleason’s leadership at CECO (CECO) highlights strong contract wins, but questions remain about his ability to improve free cash flow and margin discipline. Continue reading →

Preston Wigner’s limited experience and compliance issues may challenge his fit as CEO of Universal Corp. (UVV) amid urgent operational needs and change. Continue reading →

Jason Murray’s leadership at PACS (PACS) may face challenges due to governance concerns and key skill gaps, raising questions about his fit for the turnaround. Continue reading →

Brett Heffes’s capital discipline supports Winmark Corp. (WINA), but challenges with franchisee relations may impact growth and premium valuation defense. Continue reading →

Mark Marron’s M&A strengths at ePlus, Inc. (PLUS) may face challenges as margin and sales execution risks could impact his ability to drive sustained profitability. Continue reading →

David Watson’s contract wins at Argan, Inc. (AGX) highlight strengths, but limited turnaround experience may challenge his fit for driving diversification. Continue reading →

David Wang’s leadership at ACM Research (ACMR) is closely aligned with China market growth, but may face challenges meeting global diversification and risk needs. Continue reading →